Articles On Telix Pharmaceuticals (ASX:TLX)

HIGHLIGHTS Uptrending names include ANZ Group (ASX:ANZ), Liontown Resources (ASX:LTR) and Northern Star (ASX:NST). Downtrending names feature Technology One (ASX:TNE), JB Hi-Fi (ASX:JBH) and HMC Capital (ASX:HMC). Momentum s...

The Australian share market traditionally provides investors with an average return of approximately 10% per annum. While this is good, investors don't have to settle for average. Not when there are ASX 200 shares out there that analysts be...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Nov. 12, 2025 /PRNewswire/ — Telix Pharmac...

Two dozen esteemed sector figures recently gathered over lunch to recount their career highs and lows One luminary recalls an uncomfortable close encounter with a drug cartel, while others overcame the impact of academic and corporate frau...

Highlights Clear snapshot of momentum and pressure across major ASX names Concise company definitions for quick context One-stop guide with helpful ASX keyword links A concise walkthrough of prominent ASX names across...

At the start of each week, I like to look at ASIC's short position report to find out which shares are being targeted by short sellers. This is because I believe it is well worth keeping a close eye on short interest levels as high levels...

S&P/ASX 200 Index (ASX: XJO) shares are in the red on Melbourne Cup Day after the Reserve Bank kept interest rates on hold. This was widely anticipated, with the markets pricing just a 7% chance of a rate cut today after inflation s...

The S&P/ASX 200 Index (ASX: XJO) is 0.36% lower at the time of writing on Tuesday morning. Over the year, the index is 8.5% higher, and there are signals that the index could end 2025 at an all-time high. But there are some stocks t...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

Turning $20,000 into $200,000 might sound ambitious, and to be fair, it is. But it's not impossible. With time, discipline, and the power of compounding, that kind of return can be achieved without taking reckless risks or chasing market fa...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ – Telix Pharmac...

Investors on the lookout for big returns for their portfolio might want to consider Telix Pharmaceuticals Ltd (ASX: TLX) shares. That's because the team at Bell Potter believes the radiopharmaceuticals company's shares are undervalued and d...

On Wednesday, the S&P/ASX 200 Index (ASX: XJO) was out of form and tumbled into the red. The benchmark index fell 0.7% to 9,030 points. Will the market be able to bounce back from this on Thursday? Here are five things to watch: ASX 2...

The health sector on the ASX hasn't been, well, all that healthy over the past few years. According to a new report from the team at Wilsons Advisory, the locally listed health stocks have underperformed the broader market for the past f...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Is it possible general worries are simply too negative as equities continue their as...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

Highlights Healthcare names led gains in mid-session ASX trade. Telix Pharmaceuticals (ASX:TLX) delivered a strong quarterly revenue update. Tamboran Resources (ASX:TBN) advanced its Beetaloo Basin drilling program. He...

Highlights Banking and mining companies drove the market higher. Broader optimism emerged across the ASX stock market. Positive sentiment supported the ASX ordinaries stocks index. The Australian sharemarket gained mom...

Highlights Banks and miners led a broad rally on the Australian sharemarket Energy stocks weakened following global oil oversupply forecasts Rare earth and biotech sectors saw contrasting performances Australia’s AGM s...

ASX closes up 1.03% to four-day high with strong performances in healthcare, materials and financials Gold hits another all-time high – of US$4211 per ounce Telix surges 16% after reporting robust September quarter revenue from its prostat...

The S&P/ASX 200 Index (ASX: XJO) is having a strong session on Wednesday. In afternoon trade, the benchmark index is up 0.75% to 8,966.3 points. Four ASX shares that are rising more than most today are listed below. Here's why they are...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is off to the races today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $14.36. In earlier trade, shares leapt...

The Contact Energy Ltd (ASX: CEN) share price is in focus as the company released its September 2025 monthly operating report, showing mass market electricity and gas sales were 372GWh, just below last year's 389GWh. The average mass market...

The Evolution Mining Ltd (ASX: EVN) share price is in focus after the company delivered a record net mine cash flow of $366 million and lifted its cash balance to $780 million in the September 2025 quarter. What did Evolution Mining report?...

The Bank of Queensland Ltd (ASX: BOQ) share price is in focus today as the company announced a 12% increase in cash earnings after tax to $383 million and a fully franked final dividend of 20 cents per share for FY25. What did Bank of Queen...

S&P/ASX 200 Index (ASX: XJO) blue-chip shares can make some of the most appealing investments, due to the combination of their strong competitive position and long growth runway ahead. The two companies I'm going to highlight have bo...

Yesterday afternoon, Telix Pharmaceuticals Ltd (ASX: TLX) reported US$206 million in unaudited group revenue for Q3 2025, up 53% year-over-year, and upgraded its FY 2025 revenue guidance to US$800–820 million. What did Telix Pharmaceutica...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) fought hard and carved out a small gain. The benchmark index rose 0.2% to 8,899.4 points. Will the market be able to build on this on Wednesday? Here are five things to watch: ASX 200 expec...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 /PRNewswire/ – Telix Pharmac...

A surge in September-quarter earnings has led Melbourne-based Telix Pharmaceuticals’ (ASX: TLX) to upgrade its full-year revenue forecast to a high of US$820 million ($1.26 billion) as the company’s growth was driven by the launch of new pr...

With the average dividend yield from the S&P/ASX 200 Index (ASX: XJO) dropping below 3.5% this year, this exchange-traded fund (ETF) certainly catches the eye with its 9% trailing gross distribution yield. According to Betashares, t...

Highlights Gold and critical minerals lead midday momentum across large, mid, and small names Defensive infrastructure and logistics display steady relative strength Technology, healthcare, and consumer brands face pressure...

For long-term investors, finding quality Australian stocks that can grow their earnings year after year is the ultimate goal. These are the kinds of businesses you can buy, tuck away, and confidently hold through market ups and downs. They...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin This week's In Brief presents two stocks which have fallen due to extraneous factors...

Telix Pharmaceuticals Ltd (ASX: TLX) is one of the ASX shares with the most buy recommendations right now. According to the recommendations collated by Commsec, the business is currently rated as a buy by 15 different analysts. It's r...

Highlights Lithium and critical mineral stocks gain momentum Consumer and tech sectors experience weakness Broader sentiment sways amid shifting rate outlook Australian AGM season sparks interest as top ASX Ordinaries...

The Australian share market may be hovering near record highs, but that doesn't mean opportunities have disappeared. In fact, every market cycle creates its own pockets of value, sometimes hiding in plain sight. While parts of the ASX are l...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A summary of the highlights from Broker Call Extra updates throughout the week past....

It was another bumpy session for ASX shares and the S&P/ASX 200 Index (ASX: XJO) this Wednesday. After narrowly missing out on a rise yesterday, investors were in for a similar experience today, with...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 30, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited...

ASX up 75 points to 8862.8 with 9 sectors higher Healthcare, banks and gold stocks drive gains Energy, info tech languish in the red   ASX pushes higher alongside spot gold The ASX 200 hummed higher throughout the day, closing out up 0.86...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

Australian shares are heading into Week 40 in the green, according to ASX 200 futures, though whether that +0.4% gain holds through the trading week is up in the air, considering we have a Reserve Bank cut call looming. Listen to the Hot...

ASX crawls up just 0.17pc with 7 sectors lower Healthcare sharply lower as Trump threatens tariffs on pharmaceuticals Strength in resources and banks outweighs greater market losses   Markets take stock as tariffs fire back up After a pol...

Highlights US pharma tariffs weigh on leading Australian healthcare stocks Silver outpaces gold in the commodities race Energy sector advances on European project updates Global tariffs weighed on healthcare names like...

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

It has been a tough finish to the week for the healthcare sector. In afternoon trade, the S&P/ASX 200 Health Care index is down 1.4%. This compares unfavourably to a small gain by the broader ASX 200 index. Here's the current state of p...

It has been a difficult year for owners of Telix Pharmaceuticals Ltd (ASX: TLX) shares. A series of disappointing announcements has put significant pressure on the radiopharmaceuticals company's shares. However, Bell Potter notes that there...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a mildly positive session and finished the day a fraction higher. The benchmark index rose 0.1% to 8,773 points. Will the market be able to bounce back from this on Friday and end the...

Highlights Several ASX-listed companies hit fresh yearly lows after earnings results. Weak outlooks and missed targets dominated across diverse sectors. Healthcare and consumer names emerged as focal points of investor conce...